Serialization helps ensure life science companies' product integrity
QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB), a leading provider of cloud enterprise resource planning (ERP) solutions and services for global manufacturers, announced today the launch of its serialization solution to help life science companies meet the impending requirements of the U.S. Food and Drug Administration's Drug Quality And Security Act (DQSA).
The DQSA outlines critical steps life science manufacturers must undertake to build an electronic, interoperable system to identify and trace prescription drugs distributed in the United States. This legislation is designed to help maintain patient safety while also deterring the production and distribution of counterfeit drugs.
QAD's serialization solution allows for the integration of serialized line-level data and operational data and fully supports key customer requirements for lot and unit-level product tracking. It also simplifies regulatory compliance, manages serialized product and supports chain of custody tracking.
"QAD's serialization solution manages packaging down to the smallest sellable unit with unique unit serial numbers, one of the requirements life science manufacturers must meet to comply with the DQSA legislation," stated Bart Reitter, director, QAD Life Sciences. "In addition, our solution provides robust track and trace functionality which simplifies product recalls and helps protect consumers by helping to authenticate products and reduce counterfeits."